Cleared Traditional

K241589 - Ceribell Seizure Detection Software

K241589 is an FDA 510(k) clearance for Ceribell Seizure Detection Software, manufactured by Ceribell, Inc.. The device is a Class 2 Neurology device with product code OMB cleared through the Traditional 510(k) pathway after a 310-day FDA review.

K241589 · Ceribell, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2025
Decision
310d
Days
Class 2
Risk

K241589 is an FDA 510(k) clearance for the Ceribell Seizure Detection Software. Classified as Automatic Event Detection Software For Full-montage Electroencephalograph (product code OMB), Class II - Special Controls.

Submitted by Ceribell, Inc. (Sunnyvale, US). The FDA issued a Cleared decision on April 9, 2025 after a review of 310 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1400 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Ceribell, Inc. devices

FDA 510(k) Submission Details - K241589

510(k) Number K241589 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 03, 2024
Decision Date April 09, 2025
Days to Decision 310 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized Yes - Predetermined Change Control Plan authorized FDA has pre-authorized specific future modifications to this device, a pathway common in AI/SaMD devices.
Regulatory Context
Review time vs. panel average
162d slower than avg
Panel avg: 148d · This submission: 310d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. PCCP authorized - AI/SaMD pathway.

OMB Device Classification - Class 2, Special Controls

Product Code OMB Automatic Event Detection Software For Full-montage Electroencephalograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Automatically Mark Or Identify Electroencephalograph Waveforms For Spikes, Electrographic Seizures, Seizure-like Events In Order To Aid In Identification Of Such Events And Help Review And Annotation Of Prolonged Eeg Traces; All Output Subject To Verification By Qualified User
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - OMB Automatic Event Detection Software For Full-montage Electroencephalograph

All 22
Devices cleared under the same product code (OMB) and FDA review panel - the closest regulatory comparables to K241589.
Ceribell Infant Seizure Detection Software
K252070 · Ceribell, Inc. · Nov 2025
Persyst 15 EEG Review and Analysis Software (Persyst 15 (P15))
K252160 · Persyst Development, LLC · Oct 2025
autoSCORE (V 2.0.0)
K243743 · Holberg Eeg AS · Apr 2025
Persyst 15 EEG Review and Analysis Software (Persyst 15 (P15))
K242446 · Persyst Development Corporation · Jan 2025
NeuroMatch
K241390 · LVIS Corporation · Nov 2024
REMI-AI Rapid Detection Module (REMI-AI RDM)
K240408 · Epitel, Inc. · Oct 2024